Human Vitamin D Receptor Mutations: Identification of Molecular Defects in Hypocalcemic Vitamin D Resistant Rickets

  • Mark Hughes
  • Peter Malloy
  • Dirk Kieback
  • Donald McDonnell
  • David Feldman
  • J. Wesley Pike
  • Bert O’Malley
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 255)


Our laboratories have been interested in the mechanism by which steroid receptors in general, and the 1,25-dihydroxyvitamin D (1,25(0H)2D) receptor specifically, interact with sequences in the target cell genome and regulate the transcription of specific gene products. Elucidation of these structure-function relationships of the l,25-(OH)2D3 receptor macromolecule have been hampered primarily because of its extremely low intracellular concentration (0.001%), even in primary target tissues such as intestine. This concentration is less than onetenth the cellular concentration of other steroid receptor molecules. Nonetheless, Pike and Haussler succeeded in purifying the chicken intestinal vitamin D receptor (1) and raised monoclonal antibodies which were reactive to both the chicken and mammalian isoforms (2). The monoclonals were used to recover vitamin D receptor (VDR) complementary DNA (cDNA) from a chicken intestine expression library (3). Subsequently, the chicken clones were used as probes to screen several human cDNA libraries and isolate the mammalian full length cDNA encoding the VDR (4). The nucleotide sequence of the 4605 base pair human cDNA was shown to include 1281 bp of open reading frame, 115 bp of noncoding leader sequence, and 3209 bp of 3′- noncoding sequence. The cloned sequence was subsequently transfected into COS-1 receptor negative monkey kidney cells and a single VDR species was produced that was indistinguishable from the native receptor (4).


Hormone Binding Thyroid Receptor Hormone Binding Domain Resistant Rickets Rickets Type 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J.W. Pike, S. Marion, C.A. Donaldson, M.R. Haussler, Serum and Monoclonal Antibodies against the chick intestinal receptor for 1,25-dihydroxyvitamin D3, J Biol Chem 258:1289 (1983).PubMedGoogle Scholar
  2. 2.
    J.W. Pike, Monoclonal antibodies to chick intestinal receptors for 1,25-dihydroxyvitamin D, J Biol Chem 259:1167 (1984).PubMedGoogle Scholar
  3. 3.
    D. McDonnell, D. Mangelsdorf, J. Pike, M. Haussler, B.W. O’Malley, Molecular cloning of complementary DNA encoding the avian receptor for vitamin D, Science 235:1214 (1987).PubMedCrossRefGoogle Scholar
  4. 4.
    A. Baker, D. McDonnell, M. Hughes, T. Crisp, D. Mangelsdorf, M. Haussler, J. Pike, J. Shine, B. O’Malley, Cloning and expression of full length cDNA encoding human vitamin D receptor, Proc Natl Acad Sci, USA 85:3294 (1988).PubMedCrossRefGoogle Scholar
  5. 5.
    R. Evans, The steroid and thyroid receptor superfamily, Science 240:889 (1988).PubMedCrossRefGoogle Scholar
  6. 6.
    J. Miller, A. McLachlan, A. Klug, EMBO Journal 4:1609 (1985).PubMedGoogle Scholar
  7. 7.
    F. Albright, A.M. Butler, E. Bloomberg, Rickets resistant to vitamin D therapy, Am J Dis Child 54:531 (1937).Google Scholar
  8. 8.
    D. Fraser, R.B. Salter, The diagnosis and management of the various types of rickets, Pediatr Clin N Am 5:417 (1958).Google Scholar
  9. 9.
    T.M. Reade, C.R. Scriver, F.H. Glorieus, B. Nogrady, E.E. Delvin, M.F. Holick, H.F. DeLuca, Response to crystalline 1α-hydroxyvitamin D3 in vitamin D dependency, Pediatr Res 9:593 (1975).PubMedCrossRefGoogle Scholar
  10. 10.
    S.J. Marx, A.M. Speigel, E.M. Brown, D.G. Gardner, R.W. Pouns, Jr., M. Affie, A.J. Hamstra, H.F. DeLuca, A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D, J Clin Endocrinol Metab 47:1303 (1978).PubMedCrossRefGoogle Scholar
  11. 11.
    J.S. Adams, T.O. Wahl, W.V. Moore, W.A. Horton, B.P. Lukert, Familiar vitamin D-dependent rickets: further evidence for end organ resistance to active vitamin D metabolites. Program and Abstracts, 61st Annual Meeting of the Endocrine Society, 1979 767 (abstract).Google Scholar
  12. 12.
    M.H. Brooks, N.H. Bell, L. Love, P.H. Stern, E. Orfei, S.F. Queener, A.J. Hamstra, H.F. DeLuca, Vitamin-D-dependent rickets type II, resistance of target organs to 1,25-dihydroxyvitamin D, N Engl J Med 298:996 (1978).PubMedCrossRefGoogle Scholar
  13. 13.
    J.E. Zerwekh, K. Glass, J. Jowsey, C.Y.C. Pak, An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J. Clin Endocrinol. Metab 49:171 (1979).PubMedCrossRefGoogle Scholar
  14. 14.
    T. Fujita, M. Nomura, S. Okajima, H. Furuya, Adult onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone, J Clin Endocrinol Metab 50:927 (1980).PubMedCrossRefGoogle Scholar
  15. 15.
    T. Kudoh, T. Kumagai, N. Uetsuji, S. Tsugawa, K. Oyanagi, Y. Chiba, T. Minami, T. Nakao, Vitamin D dependent rickets: decreased sensitivity to 1,25-dihydroxyvitamin D, Eur J Pediatr 137:307 (1981).PubMedCrossRefGoogle Scholar
  16. 16.
    S. Yoshikawa, T. Nakamura, Y. Nishii, Vitamin D dependent rickets with limited response to 1αOHD3 and high serum l,25-(OH)2D levels-long term follow-up, in: “Vitamin D: Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism”, A.W. Norman K. Schaefer, D.V. Herrath, H-G Grigoleit (eds.). Walter de Gruyter, New York (1982).Google Scholar
  17. 17.
    J.F. Rosen, A.R. Fleischman, L. Finberg, A. Hamstra, H.F. DeLuca, Rickets with alopecia: an inborn error of vitamin D. metabolism, J Pediatr 94:729 (1979).PubMedCrossRefGoogle Scholar
  18. 18.
    U.A. Liberman, R. Samuel, A. Halabe, R. Kauli, S. Edelstein, Y. Weisman, S. Papapoulos, T.L. Clemens, L.J. Fraher, J.L.H. O’Riordan, End-organ resistance to 1,25-dihydroxycholecalciferol, Lancet 1:504(1980).PubMedCrossRefGoogle Scholar
  19. 19.
    Y. Tsuchiya, N. Matsuo, H. Cho, M. Kumagai, M. Yasaka, T. Suda, H. Orimo, M. Shiraki, An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biolgically active Vitamin D. J Clin Endocrinol Metab 51:685 (1980).PubMedCrossRefGoogle Scholar
  20. 20.
    D. Feldman, T. Chen, C. Cone, M. Hirst, S. Shani, A. Benderli, Z. Hochberg, Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25-(OH)2D3, J Clin Endocrinol 55:1020 (1982).CrossRefGoogle Scholar
  21. 21.
    J.J. Sockalosky, R.A. Ulstrom, H.F. DeLuca, D.M. Brown, Vitamin D-resistant rickets: end organ unresponsiveness to l,25-(OH)2D3, J Pediatr 96:701 (1980).PubMedCrossRefGoogle Scholar
  22. 22.
    S. Beer, M. Tieder, D. Kohelet, V.A. Liberman, E. Vure, G. Bar-Joseph, D. Gabizon, V. Borochowitz, M. Varon, D. Modai, Vitamin-D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D, Clin Endocrinol 14:395 (1981).CrossRefGoogle Scholar
  23. 23.
    J.E. Griffin, J.S. Chandler, M.R. Haussler, J.E. Zerwekh, Receptor-positive resistance to 1,25 dihydroxyvitamin D3: a new cause of osteomalacia associated with impaired induction of 24-hydroxylase in fibroblasts, Clin Res 30:524A (1982).Google Scholar
  24. 24.
    T. Chen, Z. Hochberg, A. Benderli, S. Stanford, C. Cone, D. Feldman, Vitamin D-resistant rickets with alopecia: defective cytoplasmic receptors for l,25-(OH)2D3 in cultured skin fibroblasts, Abstracts at the Fourth Annual Meeting of the American Society for Bone and Mineral Research, S-49 (1982).Google Scholar
  25. 25.
    U.A. Lieberman, S. Balsan, S.J. Marx, True resistance to 1,25 dihydroxyvitamin D-cellular basis and implication of a new congenital syndrome, Abstracts of the 64th Meeting of the Endocrine Society (1982).Google Scholar
  26. 26.
    C. Eil, U.A. Lieberman, J.F. Rosen, S.J. Marx, A cellular defect in hereditary vitamin D-dependent rickets type II: defective nuclear uptake if 1,25 dihydroxyvitamin D in cultured skin fibroblasts, N Engl J Med 304:1588 (1981).PubMedCrossRefGoogle Scholar
  27. 27.
    P.J. Malloy, Z. Hochberg, J.W. Pike, D. Feldman, Vitamin D dependent rickets, type II: vitamin D receptor analysis in cultured fibroblasts from patients and parents exhibiting normal steroid binding but decreased DNA binding, Clin Endocrinol and Metab (submitted).Google Scholar
  28. 28.
    T.L. Chen, M.A. Hirst, C.M. Cone, Z. Hochberg, H-U Tietze, D. Feldman, 1,25 dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents, J Clin Endocrinol Metab 59:383 (1984).PubMedCrossRefGoogle Scholar
  29. 29.
    Z. Hochberg, A. Benderli, J. Levy, P. Vardi, Y. Weisman, T. Chen, D. Feldman, 1,25-dihydroxyvitamin D resistance, rickets and alopecia, Am J Med 77:805 (1984).PubMedCrossRefGoogle Scholar
  30. 30.
    M.A. Hirst, H.I. Hochman, D. Feldman, Vitamin D resistance and alopecia: a kindred with normal 1,25 dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleac acid, J Clin Endocrinol Metab 60:490 (1985).PubMedCrossRefGoogle Scholar
  31. 31.
    T.L. Clements, J.S. Adams, N. Horiuchi, B.A. Cilchrest, H. Cho, Y. Tsuchiya, N. Matsuo, T. Suda, M.F. Holick, Interaction of 1,25 dihydroxyvitamin D3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vitamin D-dependent rickets, type II: a model for study of the mode of action of 1,25-dihydroxyvitamin D3, J. Clin Encodrinol Metab 56:824 (1983).CrossRefGoogle Scholar
  32. 32.
    W.E. Stumpf, M. Sar, F.A. Reid, Y. Tanaka, H.F. DeLuca, Target cells for 1,25-dihydroxyvitamin D in intestinal tract, kidney, skin, pituitary and parathyroid, Science 206: 1188 (1979).PubMedCrossRefGoogle Scholar
  33. 33.
    K. Colston, M. Hirst, D. Feldman, Organ distribution of the cytoplasmic 1,25-dihydroxyvitamin D receptor in various mouse tissues, Endocrinology 107:1916 (1980).PubMedCrossRefGoogle Scholar
  34. 34.
    D. Feldman, T. Chen, M. Hirst, K. Colston, M. Karasek, C. Cone, Demonstration of 1,25-dihydroxyvitamin D receptors in human skin biopsies. J. Clin. Endocrinol. Metab. 51:1463 (1980).PubMedCrossRefGoogle Scholar
  35. 35.
    D. Feldman, T.A. McCain, M.A. Hirst, T.L. Chen, K.W. Colston, Characterization of a cytoplasmic receptor-like binder for 1,25 dihydroxycholecalciferol in rat intestinal mucosa, J Biol Chem 254:10378 (1979).PubMedGoogle Scholar
  36. 36.
    J.S. Chandler, S.K. Chandler, J.W. Pike, M.R. Haussler, 1,25 dihy-droxyvitamin D3 induces 25-dihydroxyvitamin D3-24-hydroxylation in a cultured monkey kidney cell line (LLC-MK2) apparently deficient in the high affinity receptor for the hormone, J. Biol Chem 259:2214.Google Scholar
  37. 37.
    D.J. Mangelsdorf, J.W. Pike, M.R. Haussier, Avian and mammalian receptors for 1,25-dihydroxyvitamin D: In vitro translation to characterize size and hormone-dependent regulation. Proc Natl Acad Sci USA 84: 354 (1987).PubMedCrossRefGoogle Scholar
  38. 38.
    U.A. Lieberman, C. Eil, S.J. Marx, Receptor-positive hereditary resistance to 1,25-dihydroxyvitamin D: chromatography of hormone receptor complexes on deoxyribonucleic acid-cellulose shows two classes of mutation. J Clin Endocrinol Metab (1986).Google Scholar
  39. 39.
    R. Saiki, S. Scharf, F. Faloona, K. Mullis, G.T. Hoorn, N. Arnheim, Polymerase chain reaction, Science 230:1350–1354 (1985).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Mark Hughes
    • 1
    • 2
  • Peter Malloy
    • 1
    • 2
  • Dirk Kieback
    • 1
    • 2
  • Donald McDonnell
    • 1
    • 2
  • David Feldman
    • 1
    • 2
  • J. Wesley Pike
    • 1
    • 2
  • Bert O’Malley
    • 1
    • 2
  1. 1.Departments of Cell Biology, Genetics, and PediatricsBaylor College of MedicineHoustonUSA
  2. 2.Department of MedicineStanford University Medical CenterStanfordUSA

Personalised recommendations